A detailed history of Sachetta, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Sachetta, LLC holds 66 shares of BIIB stock, worth $10,421. This represents 0.01% of its overall portfolio holdings.

Number of Shares
66
Previous 96 31.25%
Holding current value
$10,421
Previous $20.3 Million 37.11%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$189.07 - $236.8 $5,672 - $7,104
-30 Reduced 31.25%
66 $12.8 Million
Q2 2024

Aug 07, 2024

BUY
$190.52 - $236.72 $4,763 - $5,918
25 Added 35.21%
96 $20.3 Million
Q4 2023

Feb 09, 2024

BUY
$222.59 - $267.94 $15,803 - $19,023
71 New
71 $18.4 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Sachetta, LLC Portfolio

Follow Sachetta, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sachetta, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sachetta, LLC with notifications on news.